FOR IMMEDIATE DISTRIBUTION ACETADOTE® APPROVED IN AUSTRALIA FOR TREATMENT OF ACETAMINOPHEN POISONING Cumberland Pharmaceuticals partnering with Phebra Pty Ltd. for Australian marketing and distribution NASHVILLE, Tenn., (May 11, 2010) – Cumberland Pharmaceuticals Inc. (Nasdaq:CPIX) and Phebra Pty Ltd. today announced that Acetadote ( acetylcysteine ) Injection ha
Advantag of ingestion administration way is its easiness even when applied at home. But with their help necessary treatment concentration in blood cannot be always quickly achieve doxycycline online transaction is carried out on anonymity and mutual profit principles, and in addition customers will be positively surprised with quality and speed of service.
Medical form 2011-12MEDICAL INFORMATION
2011 - 2012
PLEASE PRINT. Form must be returned by July 1. Student may not attend class if form is not on file.
THE FOLLOWING INFORMATION MUST BE COMPLETED AND SIGNED BY THE STUDENT’S PARENT/GUARDIAN.
HOSPITAL PREFERENCE (for non-emergencies only)
Significant health condition and/or chronic illnesses (e.g., asthma, diabetes, seizures) *
Allergies (food, insects, medications, etc.)
Prescription and non-prescription medications taken regularly or frequently at home (must be listed) *
∗ IMPORTANT: Please contact the school nurse the week before the first day of school if your daughter has a significant health
condition and/or chronic illness listed above, or if she needs emergency medicine (e.g., Epi-Pen, Glucagon, asthma inhaler) at school. The nurse may be reached at 269-1238. Medications the school may administer (must check al that apply – no medications wil be given unless indicated on this form)
Topical analgesic (Benadryl cream, gel) Dental anesthetic gel (Orajel) First aid antibiotic cream (Neosporin) Benadryl (for allergic reactions) Please cal parent/guardian before giving medications. MEDICAL EMERGENCY RELEASE
In the event that any il ness or injury occurs, and it is not possible to contact me, my designated contact persons, or my designated physician, I authorize the Academy of the Sacred Heart to obtain emergency medical, surgical, or dental treatment for my daughter. SIGNATURE REQUIRED
Parent/Guardian’s name (Please print.) MEDICAL INFORMATION RELEASE
In order to best meet the education and developmental needs of your daughter, it is important that her faculty know about any medical
condition that she may experience and any medications prescribed for her.
I authorize the school nurse to inform the administration, faculty, and staff of my daughter’s health condition and/or medicines
I do not authorize the release of information about my daughter’s health.
Parent/Guardian’s name (Please print.) OVER …
MEDICAL EVALUATION AND IMMUNIZATION RECORD
THE FOLLOWING INFORMATION MUST BE COMPLETED AND SIGNED BY THE STUDENT’S PHYSICIAN OR
PHYSICIAN’S OFFICE. THIS INFORMATION WILL BE TREATED IN A CONFIDENTIAL MANNER.
To be completed for students entering ASH-FIN, Little Hearts, PK, grades 1, 5, 9, and for all new students.
Date of last examination (must be within the last six months)
Other (Please mark with a if satisfactory or an X if not satisfactory.)
Date last given
This student may participate in the fol owing
Exceptions / special problems / dietary restrictions / recurring abnormalities /
prescribed medications / allergies
To be completed for students entering ASH-FIN, Little Hearts, PK, K, grades 1-9, and for all new students.
Month, day, and year dose was given
Date of next immunization
I certify that this child has received the above noted immunizations and is in compliance with rules set forth by the state of Louisiana, Department of Health and Hospitals, Office of Public Health. Physician’s signature x SIGNATURE REQUIRED
Academy of the Sacred Heart Medical Information 2011-2012
Organische Stoffe – Analysenumfang Stand: Juli 2010 Dieses Verzeichnis wird ständig erweitert. Sollte der von Ihnen gesuchte Stoff nicht aufgelistet sein, kontaktieren Sie uns bitte unter +43-(0)1-313 04/5126 oder senden Sie uns ein E-Mail an pruefstel [email protected] 1-(4-Isopropylphenyl)-3-methylurea (Desmethylisoproturon) 1,2,3,4,6,7,8-Heptachlordibenzofuran 6